BIOMAT Database Logo BIOMAT Database Logo

Apoptosis and Bbcl-2 expression in gastric carcinomas: correlation withclinicopathological variables, p53 expression, cell proliferation and prognosis. 1999

K Aizawa, and K Ueki, and S Suzuki, and H Yabusaki, and T Kanda, and T Nishimaki, and T Suzuki, and K Hatakeyama
First Department of Surgery, Niigata City General Hospital, Niigata 950-8739, Japan.

We investigated apoptosis and Bcl-2 expression in 221 advanced gastric carcinomas in correlation with clinicopathological variables, p53 expression, cell proliferation and prognosis, using the in situ DNA nick end labeling method and immunohistochemistry. Apoptosis was associated with high immunoreactivity of proliferating cell nuclear antigen. Bcl-2 expression correlated with a low apoptotic index and less malignant behavior of tumors. Prognostically, Bcl-2 expression was associated with a better prognosis, whereas p53 expression was the most important prognostic risk factor. Thus, apoptosis in gastric carcinomas is associated with cell proliferation, and Bcl-2 expression may have a prognostic importance as well as p53 expression.

UI MeSH Term Description Entries
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D018809 Proliferating Cell Nuclear Antigen Nuclear antigen with a role in DNA synthesis, DNA repair, and cell cycle progression. PCNA is required for the coordinated synthesis of both leading and lagging strands at the replication fork during DNA replication. PCNA expression correlates with the proliferation activity of several malignant and non-malignant cell types. Antigen, Proliferating Cell Nuclear,PCNA

Related Publications

K Aizawa, and K Ueki, and S Suzuki, and H Yabusaki, and T Kanda, and T Nishimaki, and T Suzuki, and K Hatakeyama
Incidence of apoptosis, cell proliferation and P53 expression in renal cell carcinomas.
January 1997, Anticancer research,
K Aizawa, and K Ueki, and S Suzuki, and H Yabusaki, and T Kanda, and T Nishimaki, and T Suzuki, and K Hatakeyama
p53, ER, and Ki67 Expression in Canine Mammary Carcinomas and Correlation With Pathological Variables and Prognosis.
March 2021, Veterinary pathology,
K Aizawa, and K Ueki, and S Suzuki, and H Yabusaki, and T Kanda, and T Nishimaki, and T Suzuki, and K Hatakeyama
Apoptosis and cell proliferation in the development of gastric carcinomas: associations with c-myc and p53 protein expression.
September 2002, Journal of gastroenterology and hepatology,
K Aizawa, and K Ueki, and S Suzuki, and H Yabusaki, and T Kanda, and T Nishimaki, and T Suzuki, and K Hatakeyama
Apoptosis and cell proliferation: correlation with BCL-2 and P53 oncoprotein expression in human hepatocellular carcinoma.
January 2014, Hepato-gastroenterology,
K Aizawa, and K Ueki, and S Suzuki, and H Yabusaki, and T Kanda, and T Nishimaki, and T Suzuki, and K Hatakeyama
Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: immunohistochemical and clinicopathological study.
January 1997, British journal of cancer,
K Aizawa, and K Ueki, and S Suzuki, and H Yabusaki, and T Kanda, and T Nishimaki, and T Suzuki, and K Hatakeyama
Quantitative analysis of p53 expression and cell proliferation in gastric carcinomas. An immunohistochemical study.
January 2004, Hepato-gastroenterology,
K Aizawa, and K Ueki, and S Suzuki, and H Yabusaki, and T Kanda, and T Nishimaki, and T Suzuki, and K Hatakeyama
Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression.
January 1997, British journal of cancer,
K Aizawa, and K Ueki, and S Suzuki, and H Yabusaki, and T Kanda, and T Nishimaki, and T Suzuki, and K Hatakeyama
bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.
March 1996, American journal of clinical pathology,
K Aizawa, and K Ueki, and S Suzuki, and H Yabusaki, and T Kanda, and T Nishimaki, and T Suzuki, and K Hatakeyama
The role of apoptosis, cell proliferation index, bcl-2, and p53 in glioblastoma prognosis.
June 2004, Arquivos de neuro-psiquiatria,
K Aizawa, and K Ueki, and S Suzuki, and H Yabusaki, and T Kanda, and T Nishimaki, and T Suzuki, and K Hatakeyama
Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas.
December 2004, Journal of clinical pathology,
Copied contents to your clipboard!